Role of Hydroxyapatite and Ellagic Acid in the Osteogenesis.
Journal
European journal of dentistry
ISSN: 1305-7456
Titre abrégé: Eur J Dent
Pays: Germany
ID NLM: 101303672
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
pubmed:
21
7
2020
medline:
21
7
2020
entrez:
21
7
2020
Statut:
ppublish
Résumé
Ellagic acid (EA), a phenolic antioxidant, has benefits in bone health and wound healing. The combination of EA and hydroxyapatite (HA) (EA-HA) is expected to increase osteogenesis. The aim of this study was to analyze osteogenesis after application of EA-HA according to the number of osteoblasts and osteoclasts in the bone and the expression of the receptor activator of nuclear factor kappa-B ligand (RANKL), osteoprotegerin (OPG), and osteocalcin (OCN) protein. Thirty Wistar rats were assessed with bone defects created in the left femur. The defects were filled with EA-HA and then sutured. Control groups were filled with polyethylene glycol (PEG) or HA. Each group was sacrificed either 7 or 14 days after treatment. The defects filled with EA-HA exhibited the highest number of osteoblasts and the greatest expression of OPG and OCN at both day 7 and day 14 ( EA-HA can increase osteogenesis in bone defects by increasing the number of osteoblasts and the expression of OPG and OCN.
Identifiants
pubmed: 32688409
doi: 10.1055/s-0040-1714039
pmc: PMC7906838
doi:
Types de publication
Journal Article
Langues
eng
Pagination
8-12Informations de copyright
European Journal of Dentistry. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Déclaration de conflit d'intérêts
None declared.
Références
Int J Endocrinol. 2013;2013:846480
pubmed: 23737779
J Nanosci Nanotechnol. 2014 Jan;14(1):15-56
pubmed: 24730250
Anticancer Res. 2013 May;33(5):1829-36
pubmed: 23645727
Heliyon. 2018 Nov 02;4(10):e00884
pubmed: 30417149
Clin Interv Aging. 2017 Sep 13;12:1481-1494
pubmed: 28979109
Curr Rev Musculoskelet Med. 2009 Mar;2(1):56-64
pubmed: 19468919
Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):209-216
pubmed: 29263736
Chem Biol Interact. 2014 Aug 5;219:64-75
pubmed: 24877639
ScientificWorldJournal. 2014;2014:908098
pubmed: 25485304
Molecules. 2011 Mar 11;16(3):2365-74
pubmed: 21399573
Arch Oral Biol. 2014 Sep;59(9):987-99
pubmed: 24952163
Int J Mol Sci. 2019 Jul 22;20(14):
pubmed: 31336616
J Mater Chem B. 2014 Jun 7;2(21):3161-3184
pubmed: 24999429
Orthod Craniofac Res. 2009 May;12(2):113-9
pubmed: 19419454
Tissue Eng Part B Rev. 2008 Jun;14(2):179-86
pubmed: 18544015
Biomed Res Int. 2020 Feb 19;2020:6910312
pubmed: 32149122
Stem Cells Dev. 2006 Feb;15(1):118-23
pubmed: 16522169
Bone. 2016 May;86:119-30
pubmed: 26946132
J Clin Periodontol. 2012 Mar;39(3):239-48
pubmed: 22092994
J Periodontol. 2013 Aug;84(8):1067-74
pubmed: 23075431
Eur J Dent. 2019 May;13(2):271-279
pubmed: 31487751
Rheumatology (Oxford). 2016 Oct;55(10):1714-25
pubmed: 26790456
Calcif Tissue Int. 2016 Aug;99(2):209-23
pubmed: 27075029
Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):846-852
pubmed: 27867890
Cells Tissues Organs. 2011;194(2-4):313-9
pubmed: 21576907